The efficacy of cancer medications is determined through a series of clinical trials. These trials are designed to assess the drug's effectiveness, safety, and overall impact on the patient's quality of life. The process includes multiple phases, starting from small-scale trials to large, randomized controlled trials. Regulatory bodies like the FDA and EMA review the data to approve or disapprove the drug for specific indications.
